Squamous Intraepithelial Lesions: Clinical Trials

1 trial for Squamous Intraepithelial Lesions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Squamous Intraepithelial Lesions: new trials by email Literature Review of Squamous Intraepithelial Lesions trials Research Report on Squamous Intraepithelial Lesions

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Glizigen, Placebo - Papilloma Viral Infection, CIN1
Phase 4UnknownCatalysis SL1202023-06-072024-02-07

Narrower conditions

Papillomavirus Infections (1)

Broader conditions

Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Infections (1)  ·  Morphological and Microscopic Findings (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Tumor Virus Infections (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Sponsors

Catalysis SL (1)

Countries

Spain (1)